OBI-1
OBI-1-302
Phase 3 mab terminated
Quick answer
OBI-1 for Hemophilia A is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Hemophilia A
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated